Aridis Pharmaceuticals
(OTC) ARDS
Aridis Pharmaceuticals Financials at a Glance
Market Cap
$8,900
Revenue (TTM)
$20.06M
Net Income (TTM)
$1.14M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-43.43 (Low)
Dividend
$0.00
Beta (Volatility)
-43.43 (Low)
Price
$0.00
Volume
1
Open
$0.00
Price
$0.00
Volume
1
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Dividend
$0.00
Beta (Volatility)
-43.43 (Low)
Price
$0.00
Volume
1
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
ARDS News
ARDS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aridis Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
37
CEO
Vu L. Truong, PhD
Website
www.aridispharma.comHeadquarters
Los Gatos, CA 95032, US
ARDS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
1%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.90K
Shares Outstanding
44.57M
Volume
1
Short Interest
0.00%
Avg. Volume
10.77K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$29.99M
EBITDA
$29.51M
Operating Cash Flow
$29.13M
Capital Expenditure
$82.00K
Free Cash Flow
$29.21M
Cash & ST Invst.
$4.88M
Total Debt
$6.13M
Aridis Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$417.00K
N/A
Gross Profit
$417.00K
N/A
Gross Margin
100.00%
N/A
Market Cap
$8.90K
N/A
Market Cap/Employee
$240.54
N/A
Employees
37
N/A
Net Income
$83.00K
+99.1%
EBITDA
$810.00K
+88.9%
Quarterly Fundamentals
Net Cash
$4.80M
+60.6%
Accounts Receivable
$517.00K
+108.5%
Inventory
$0.00
N/A
Long Term Debt
$854.00K
-82.7%
Short Term Debt
$3.99M
-56.4%
Return on Assets
-2.09%
N/A
Return on Invested Capital
1.35%
N/A
Free Cash Flow
$983.00K
+77.0%
Operating Cash Flow
$983.00K
+77.0%